The synthetic pentasaccharide fondaparinux prevents coronary microvascular injury and myocardial dysfunction in the ischemic heart

Thrombosis and Haemostasis

Volumn 100, Issue 5, 2008, Pages 912-919

  Montaigne, David ^a,b   Marechal, Xavier ^a   Lancel, Steve ^a   Decoster, Brigitte ^a   Asseman, Philippe ^b   Neviere, Remi ^a,b  

^a IMPECS IMPact de l Environnement Chimique sur la Santé humaine   (France)

^b UNIV LILLE   (France)

Author keywords

Heart; Heparin; Ischemia reperfusion; Reactive oxygen species

Indexed keywords

CREATINE KINASE; FONDAPARINUX; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PENTASACCHARIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CRYSTALLOID; DRUG EFFECT; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMOSTASIS; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; LIPID PEROXIDATION; MALE; MICROCIRCULATION; MICROVASCULAR ISCHEMIA; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE INJURY; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 55549102347     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-04-0230     Document Type: Article

References (32)

1. Weitz JI. Emerging anticoagulants for the treatment of venous thromboembolism. Thromb Haemost 2006; 96: 274-284.
2. Bassand JP, Richard-Lordereau I, Cadroy Y. Efficacy and safety of fondaparinux in patients with acute coronary syndromes. Expert Rev Cardiovasc Ther 2007; 5: 1013-1026.
3. Cornet AD, Smit EG, Beishuizen A, Groeneveld AB. The role of heparin and allied compounds in the treatment of sepsis. Thromb Haemost 2007; 98: 579-586.
4. Frank RD, Schabbauer G, Holscher T, et al. The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia-reperfusion injury. J Thromb Haemost 2005; 3: 531-540.
5. Olanders K, Borjesson A, Zhao X, et al. Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats. Acta Anaesthesiol Scand 2005; 49: 517-524.
6. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135.
7. Frank RD, Holscher T, Schabbauer G, et al. A nonanticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury. Thromb Haemost 2006; 96: 802-806.
8. Turpie AG. Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy. Expert Opin Pharmacother 2004; 5: 1373-1384.
9. Rubio-Gayosso I, Platts SH, Duling BR. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006; 290: H2247-H2256.
10. Favory R, Lancel S, Tissier S, et al. Myocardial dysfunction and potential cardiac hypoxia in rats induced by carbon monoxide inhalation. Am J Respir Crit Care Med 2006; 174: 320-325.
11. Chilian WM, DeFily DV. Methodological approaches used for the study of the coronary microcirculation in situ. Blood Vessels 1991; 28: 236-244.
12. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008; 29: 572-576.
13. Rota C, Chignell CF, Mason RP. Evidence for free radical formation during the oxidation of 2′-7′-dichlorofluorescin to the fluorescent dye 2′-7′-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements. Free Radic Biol Med 1999; 27: 873-881.
14. Guo Z, Xia Z, Jiang J, et al. Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol 2007; 292: H1728-H1736.
15. Bleeke T, Zhang H, Madamanchi N, et al. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 2004; 94: 37-45.
16. Ludwig RJ, Alban S, Bistrian R, et al. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost 2006; 95: 535-540.
17. Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454: 345-359.
18. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-1906.
19. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 2004; 286: H1672-H1680.
20. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004; 555: 589-606.
21. Yokoyama Y, Beckman JS, Beckman TK, et al. Circulating xanthine oxidase: potential mediator of ischemic injury. Am J Physiol 1990; 258: G564-G570.
22. Hawes EM, Watts JA. Xanthine oxidase/dehydrogenase release following ischemia in isolated rat hearts. Am J Cardiovasc Pathol 1993; 4: 326-335.
23. Radi R, Rubbo H, Bush K, et al. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes. Arch Biochem Biophys 1997; 339: 125-135.
24. Cave AC, Brewer AC, Narayanapanicker A, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
25. Hoffmeyer MR, Jones SP, Ross CR, Sharp B, Grisham MB, Laroux FS et al. Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice. Circ Res 2000; 87: 812-817.
26. Bell RM, Cave AC, Johar S, et al. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J 2005; 19: 2037-2039.
27. Córdoba M, Mora N, Beconi MT. Respiratory burst and NAD(P)H oxidase activity are involved in capacitation of cryopreserved bovine spermatozoa. Theriogenology 2006; 65: 882-892.
28. Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 2003; 5: 731-740.
29. Nediani C, Borchi E, Giordano C, et al. NADPH oxidase-dependent redox signaling in human heart failure: relationship between the left and right ventricle. J Mol Cell Cardiol 2007; 42: 826-834.
30. Qin F, Shite J, Liang CS. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol 2003; 285: H822-H832.
31. Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 2008; 22: 954-965.
32. Muslin AJ. Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc Med 2005; 15: 225-229.